Clinical Report: TECLens Secures Funding for qCXL
Overview
TECLens has successfully closed a $10 million Series A2 extension financing to advance its quantitative corneal cross-linking (qCXL) platform aimed at non-invasive refractive vision correction. The funding will support clinical development, including a first-in-human proof-of-concept program and preparation for future investigational submissions.
Background
Corneal cross-linking (CXL) is a technique in ophthalmology for treating refractive errors and conditions like keratoconus. The development of non-invasive methods, such as TECLens' qCXL, is part of ongoing advancements in refractive surgery. Understanding these innovations is essential for healthcare professionals involved in vision correction.
Data Highlights
No numerical data available in the source material.
Key Findings
- TECLens has raised $10 million in Series A2 extension financing.
- The funding will support the clinical development of its qCXL platform for refractive vision correction.
- TECLens is conducting a first-in-human proof-of-concept study evaluating qCXL.
- The CXLens System aims to reshape the cornea using personalized patterns of ultraviolet light.
- TECLens plans to present updates at the ESCRS meeting and the American Academy of Ophthalmology annual meeting.
Clinical Implications
Clinicians should stay informed about ongoing studies and emerging technologies related to refractive errors.
Conclusion
TECLens' recent funding and ongoing clinical studies indicate progress in the field of refractive vision correction.
Related Resources & Content
- glaucoma physician, Quantel Completes Acquisition of Ellex, 2020 -- Quantel Completes Acquisition of Ellex
- Ophthalmology Management, QUICK HITS, 2022 -- QUICK HITS
- Ophthalmology Management, At Press Time, 2013 -- At Press Time
- Global Consensus on Keratoconus and Ectatic Diseases-Edition 2 - PubMed, 2026 -- Global Consensus on Keratoconus and Ectatic Diseases-Edition 2
- Clinical Outcomes and Safety of Customized Corneal Cross-linking for Keratoconus: A Systematic Review and Meta-analysis. - PubMed, 2026 -- Clinical Outcomes and Safety of Customized Corneal Cross-linking for Keratoconus: A Systematic Review and Meta-analysis.
- Optometric Management — O.D. NOTEBOOK
- Global Consensus on Keratoconus and Ectatic Diseases-Edition 2 - PubMed
- Clinical Outcomes and Safety of Customized Corneal Cross-linking for Keratoconus: A Systematic Review and Meta-analysis.
- Photorefractive intrastromal corneal crosslinking for the treatment of myopic refractive errors: Six-month interim findings - PubMed
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
